| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
| mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
| mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.01 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |